Sagewood Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.55M Buy
2,963
+328
+12% +$335K 0.8% 19
2026
Q1
$2.42M Buy
2,635
+293
+13% +$297K 0.76% 21
2025
Q4
$2.52M Buy
+2,342
New +$2.24M 0.89% 23

Other funds holding LLY

Sagewood Asset Management's LLY Position: Q2 2026 in Review

Sagewood Asset Management increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $335K and bringing the position to 2,963 shares worth $3.55M. The position accounts for 0.8% of the portfolio, ranked #19.

Sagewood Asset Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sagewood Asset Management held 2,963 shares of Eli Lilly worth $3.55M as of Q2 2026.
  • Sagewood Asset Management bought 328 Eli Lilly shares in Q2 2026, an estimated $335K.
  • Eli Lilly made up 0.8% of Sagewood Asset Management's portfolio in Q2 2026, its #19 holding.
  • Sagewood Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sagewood Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.